Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13550a2e931b7820247a58278354ee62 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2007-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b7f3aaa8fe6049fa884b8c15df4bb26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5702b0e9268cac19528d790e40aa272 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bbfb0b41f620306aa6733850520aeab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81ceffc71ea259d6c4b42aa877db2d22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b9b2e5b2de642726eccbf0cbbae3b97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cd9277619b7e73a6c1d1fea2d86ffac |
publicationDate |
2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2674209-A1 |
titleOfInvention |
Glp-1 pharmaceutical compositions |
abstract |
The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues. |
priorityDate |
2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |